Commerzbank Aktiengesellschaft FI boosted its stake in CME Group Inc. (NASDAQ:CME) by 46.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 38,728 shares of the company’s stock after buying an additional 12,304 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in CME Group were worth $4,467,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Mizuho Trust & Banking Co. Ltd. raised its position in CME Group by 6.6% in the second quarter. Mizuho Trust & Banking Co. Ltd. now owns 523,814 shares of the company’s stock worth $51,019,000 after buying an additional 32,581 shares during the period. Morgan Stanley raised its position in CME Group by 31.0% in the third quarter. Morgan Stanley now owns 660,320 shares of the company’s stock worth $69,017,000 after buying an additional 156,147 shares during the period. Hilton Capital Management LLC raised its position in CME Group by 14.1% in the third quarter. Hilton Capital Management LLC now owns 66,001 shares of the company’s stock worth $6,898,000 after buying an additional 8,167 shares during the period. Manitou Investment Management Ltd. raised its position in CME Group by 33.8% in the second quarter. Manitou Investment Management Ltd. now owns 166,221 shares of the company’s stock worth $16,190,000 after buying an additional 42,010 shares during the period. Finally, CENTRAL TRUST Co raised its position in CME Group by 0.5% in the third quarter. CENTRAL TRUST Co now owns 16,132 shares of the company’s stock worth $1,686,000 after buying an additional 76 shares during the period. Hedge funds and other institutional investors own 80.05% of the company’s stock.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.34% during midday trading on Friday, reaching $118.98. The company’s stock had a trading volume of 1,130,130 shares. The firm has a market capitalization of $40.23 billion, a price-to-earnings ratio of 26.26 and a beta of 0.88. The firm’s 50 day moving average is $117.65 and its 200 day moving average is $110.74. CME Group Inc. has a 52 week low of $89.00 and a 52 week high of $124.01.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 2nd. The company reported $1.14 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 7.28% and a net margin of 42.67%. The firm had revenue of $913 million for the quarter, compared to analysts’ expectations of $881.46 million. During the same quarter last year, the firm earned $0.92 earnings per share. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post $4.81 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 27th. Shareholders of record on Friday, March 10th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date is Wednesday, March 8th. This is a boost from CME Group’s previous quarterly dividend of $0.60. CME Group’s payout ratio is currently 52.98%.
A number of equities analysts have weighed in on CME shares. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $131.00 price objective on the stock in a research note on Tuesday, January 10th. J P Morgan Chase & Co lowered CME Group from an “overweight” rating to a “neutral” rating in a research note on Tuesday, January 31st. RBC Capital Markets set a $92.00 price target on CME Group and gave the company a “sell” rating in a research note on Friday, October 28th. Finally, Royal Bank Of Canada decreased their price target on CME Group from $97.00 to $92.00 and set an “underperform” rating on the stock in a research note on Friday, October 28th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. CME Group has a consensus rating of “Hold” and a consensus target price of $103.96.
In other CME Group news, CEO Terrence A. Duffy sold 17,375 shares of the business’s stock in a transaction dated Friday, November 25th. The stock was sold at an average price of $112.58, for a total transaction of $1,956,077.50. Following the transaction, the chief executive officer now owns 127,739 shares in the company, valued at $14,380,856.62. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 1,000 shares of the business’s stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $121.00, for a total value of $121,000.00. Following the transaction, the director now owns 6,099 shares in the company, valued at approximately $737,979. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 98,819 shares of company stock worth $11,554,661. 0.61% of the stock is currently owned by insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/commerzbank-aktiengesellschaft-fi-boosts-stake-in-cme-group-inc-cme/1656751.html
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.